Stocks
Funds
Screener
Sectors
Watchlists

Latest ARMISTICE CAPITAL, LLC Stock Portfolio

ARMISTICE CAPITAL, LLC Performance:
2024 Q3: 2.83%YTD: -7.43%2023: -1.65%

Performance for 2024 Q3 is 2.83%, and YTD is -7.43%, and 2023 is -1.65%.

About ARMISTICE CAPITAL, LLC and 13F Hedge Fund Stock Holdings

ARMISTICE CAPITAL, LLC is a hedge fund based in NEW YORK, NY. On 31-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $5.6 Billions. In it's latest 13F Holdings report, ARMISTICE CAPITAL, LLC reported an equity portfolio of $6.3 Billions as of 30 Sep, 2024.

The top stock holdings of ARMISTICE CAPITAL, LLC are PTCT, SUPN, INCY. The fund has invested 4.3% of it's portfolio in PTC THERAPEUTICS INC and 2.5% of portfolio in SUPERNUS PHARMACEUTICALS INC.

The fund managers got completely rid off EXACT SCIENCES CORP (EXAS), KEURIG DR PEPPER INC (KDP) and KENVUE INC stocks. They significantly reduced their stock positions in NLS PHARMACEUTICS LTD (NLSP), CAVA GROUP INC and NEUROCRINE BIOSCIENCES INC (NBIX). ARMISTICE CAPITAL, LLC opened new stock positions in PARAMOUNT GLOBAL (PARA), MERCK & CO INC (MRK) and HUBSPOT INC (HUBS). The fund showed a lot of confidence in some stocks as they added substantially to TELEFLEX INCORPORATED (TFX), DOMINOS PIZZA INC (DPZ) and STAFFING 360 SOLUTIONS INC (STAF).

ARMISTICE CAPITAL, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that ARMISTICE CAPITAL, LLC made a return of 2.83% in the last quarter. In trailing 12 months, it's portfolio return was 1.69%.

New Buys

Ticker$ Bought
paramount global21,240,000
merck & co inc20,758,100
hubspot inc19,216,300
staar surgical co18,445,000
ge healthcare technologies i17,729,500
foot locker inc16,925,200
helen of troy ltd11,504,100
energizer hldgs inc new11,166,600

New stocks bought by ARMISTICE CAPITAL, LLC

Additions to existing portfolio by ARMISTICE CAPITAL, LLC

Reductions

Ticker% Reduced
nls pharmaceutics ltd-97.5
cava group inc-96.14
neurocrine biosciences inc-81.46
gaxos.ai inc-78.64
scilex holding co-70.63
campbell soup co-68.59
madrigal pharmaceuticals inc-66.72
gsk plc-65.07

ARMISTICE CAPITAL, LLC reduced stake in above stock

Sold off

Ticker$ Sold
sangamo therapeutics inc-5,037,700
draganfly inc.-1,514,680
castellum inc-659,926
bioxcel therapeutics inc-3,823,360
nls pharmaceutics ltd-501,256
clearside biomedical inc-2,776,800
sol gel technologies-1,808,480
palatin technologies inc-3,272,300

ARMISTICE CAPITAL, LLC got rid off the above stocks

Sector Distribution

ARMISTICE CAPITAL, LLC has about 56.8% of it's holdings in Healthcare sector.

Sector%
Healthcare56.8
Others14.5
Consumer Cyclical11.4
Technology7.9
Consumer Defensive6.6
Communication Services1.1

Market Cap. Distribution

ARMISTICE CAPITAL, LLC has about 24% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
MID-CAP36.3
LARGE-CAP19.9
SMALL-CAP18.6
UNALLOCATED16.2
MEGA-CAP4.1
MICRO-CAP3.4
NANO-CAP1.3

Stocks belong to which Index?

About 65.3% of the stocks held by ARMISTICE CAPITAL, LLC either belong to S&P 500 or RUSSELL 2000 index.

Index%
RUSSELL 200043.7
Others34.7
S&P 50021.6
Top 5 Winners (%)%
ALGS
aligos therapeutics inc
1474.5 %
SYN
theriva biologics inc
392.3 %
BIAF
bioaffinity technologies inc
282.7 %
IVDA
iveda solutions inc
255.3 %
RMTI
rockwell med inc
115.7 %
Top 5 Winners ($)$
PTCT
ptc therapeutics inc
46.3 M
TVTX
travere therapeutics inc
43.9 M
SUPN
supernus pharmaceuticals inc
23.3 M
RIGL
rigel pharmaceuticals inc
12.5 M
INCY
incyte corp
10.4 M
Top 5 Losers (%)%
IVDA
iveda solutions inc
-94.4 %
TNON
tenon medical inc
-92.4 %
SBEV
splash beverage group inc
-82.3 %
EDBL
edible garden ag inc
-76.7 %
NXL
nexalin technology inc
-69.8 %
Top 5 Losers ($)$
IRWD
ironwood pharmaceuticals inc
-19.1 M
FIVN
five9 inc
-15.9 M
NARI
inari med inc
-11.3 M
VYGR
voyager therapeutics inc
-10.7 M
NVRO
nevro corp
-10.4 M

ARMISTICE CAPITAL, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of ARMISTICE CAPITAL, LLC

ARMISTICE CAPITAL, LLC has 254 stocks in it's portfolio. About 19.5% of the portfolio is in top 10 stocks. IRWD proved to be the most loss making stock for the portfolio. PTCT was the most profitable stock for ARMISTICE CAPITAL, LLC last quarter.

Last Reported on: 14 Nov, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions